Clinical trials
Completed Phase 1/2 Cholangiocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| TransThera Sciences (Nanjing), Inc. | 2 |
| University of Zurich | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Basilea Pharmaceutica | 1 |
| Celgene | 1 |
| Elevar Therapeutics | 1 |
| FeRx | 1 |
| Forma Therapeutics, Inc. | 1 |
| Klus Pharma Inc. | 1 |
| Medivir | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 17 |
| Stomach Neoplasms | 5 |
| Biliary Tract Neoplasms | 4 |
| Breast Neoplasms | 4 |
| Bile Duct Neoplasms | 3 |
| Liver Neoplasms | 3 |
| Lung Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Urinary Bladder Neoplasms | 3 |
| Carcinoma, Hepatocellular | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.